Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eximis Surgical has developed a proprietary medical device platform for the safe and efficient removal of large tissue specimens during minimally invasive surgeries. The technology uses controlled radiofrequency (RF) energy to segment specimens within a containment bag, allowing extraction through small incisions. The company is currently in the pre-market phase with ongoing preclinical and ex vivo human tissue studies; efforts are focused on achieving FDA approval for initial commercialization.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eximis Surgical.